Cediranib, a pan-VEGFR inhibitor, and olaparib, a PARP inhibitor, in combination therapy for high grade serous ovarian cancer

Expert Opinion on Investigational Drugs
S Percy IvyElise C Kohn

Abstract

An estimated 22,000 women are diagnosed annually with ovarian cancer in the United States. Initially chemo-sensitive, recurrent disease ultimately becomes chemoresistant and may kill ~14,000 women annually. Molecularly targeted therapy with cediranib (AZD2171), a vascular endothelial growth factor receptor (VEGFR)-1, 2, and 3 signaling blocker, and olaparib (AZD2281), a poly(adenosine diphosphate [ADP]-ribose) polymerase (PARP) inhibitor, administered orally in combination has shown anti-tumor activity in the treatment of high grade serous ovarian cancer (HGSOC). This combination has the potential to change the treatment of HGSOC. Areas covered: Preclinical and clinical studies of single agent cediranib and olaparib or their combination are reviewed. Data are presented from peer-reviewed published manuscripts, completed and ongoing early phase clinical trials registered in ClinicalTrials.gov, National Cancer Institute-sponsored clinical trials, and related recent abstracts. Expert opinion: Advances in the treatment of HGSOC that improve progression-free and overall survival have proven elusive despite examination of molecularly targeted therapy. HGSOC patients with deleterious germline or somatic mutations in BRCA1 or BRCA2 (BR...Continue Reading

References

Nov 18, 1971·The New England Journal of Medicine·J Folkman
Sep 1, 1996·Molecular and Cellular Biology·J A ForsytheG L Semenza
Feb 4, 1999·The New England Journal of Medicine·L B TravisM Stovall
Feb 22, 2001·Science·R D WoodT Lindahl
May 18, 2001·Nature·J H Hoeijmakers
Oct 25, 2003·Science·Mary-Claire KingUNKNOWN New York Breast Cancer Study Group
Jun 11, 2004·Annual Review of Biochemistry·Aziz SancarStuart Linn
Sep 16, 2004·Molecular and Cellular Biology·Ranjit S BindraPeter M Glazer
Jul 20, 2005·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Alice X MengRobert G Bristow
Dec 17, 2005·Cancer Research·Ranjit S BindraPeter M Glazer
Jul 1, 2006·International Journal of Biological Sciences·Joseph A De SotoChu-Xia Deng
Aug 24, 2007·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Lucio TentoriGrazia Graziani
Sep 4, 2007·Lancet·J N Townend
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert A BurgerJoel I Sorosky
Nov 21, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stephen A CannistraWilliam McGuire
Aug 14, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard W TothillDavid D L Bowtell
Apr 21, 2009·Nature Medicine·Matina EconomopoulouTriantafyllos Chavakis
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun
Jun 26, 2009·The New England Journal of Medicine·Peter C FongJohann S de Bono
Sep 9, 2009·Nature Reviews. Clinical Oncology·S Percy IvyBennett M Kaufman
Oct 15, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ursula A MatulonisRichard T Penson
Mar 24, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yang-Min NingWilliam L Dahut
Apr 22, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter C FongStan B Kaye
Nov 26, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Daniela MateiMichael J Birrer
Jan 5, 2011·Frontiers in Bioscience (Elite Edition)·Karishma MehraChristopher P Crum
Feb 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·Anand G PatelScott H Kaufmann
Jun 15, 2011·Molecular and Cellular Biology·Yuhong LuPeter M Glazer
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Oct 19, 2011·Proceedings of the National Academy of Sciences of the United States of America·Tom WalshElizabeth M Swisher
Dec 30, 2011·The New England Journal of Medicine·Robert A BurgerUNKNOWN Gynecologic Oncology Group
Mar 29, 2012·The New England Journal of Medicine·Jonathan LedermannUrsula Matulonis
Nov 3, 2012·Cancer Research·Junko MuraiYves Pommier

❮ Previous
Next ❯

Citations

Jul 28, 2016·Current Opinion in Oncology·Alexandra LearySoizick Mesnage
Mar 18, 2017·Science·Christopher J Lord, Alan Ashworth
Apr 27, 2017·Critical Reviews in Clinical Laboratory Sciences·Khalid El BairiSaid Afqir
Nov 1, 2017·Drugs & Aging·Caroline Lum, Christopher B Steer
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Elise C Kohn, S Percy Ivy
Dec 4, 2019·Journal of Gynecologic Oncology·Yoonjung KimKyung A Lee
Jan 18, 2019·JCO Clinical Cancer Informatics·Joyce F LiuS Percy Ivy

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Related Papers

The New England Journal of Medicine
Jonathan A LedermannUrsula Matulonis
Annals of Oncology : Official Journal of the European Society for Medical Oncology
C Sessa
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Joyce F LiuUrsula Matulonis
© 2022 Meta ULC. All rights reserved